Revolution Medicines Stock Options Expiring on 21st of February
| RVMD Stock | USD 40.17 0.00 0.00% |
Revolution Medicines' latest option contracts expiring on February 21st 2025 are carrying combined implied volatility of 0.57 with a put-to-call open interest ratio of 0.0 over 30 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on February 21st 2025.
Open Interest Against February 21st 2025 Option Contracts
2025-02-21
The chart above shows Revolution Medicines' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Revolution Medicines' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Revolution Medicines' option, there is no secondary market available for investors to trade.
Revolution Medicines Maximum Pain Price Across 2025-02-21 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Revolution Medicines close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Revolution Medicines' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Revolution Medicines' stock options are financial instruments that give investors the right to buy or sell shares of Revolution Medicines common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Revolution stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Revolution Medicines' stock price goes up or down, the stock options follow.
At present, Revolution Medicines' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 3.6 B, whereas Common Stock Total Equity is forecasted to decline to 6,600. Revolution Medicines In The Money Call Balance
When Revolution Medicines' strike price is surpassing the current stock price, the option contract against Revolution Medicines stock is said to be in the money. When it comes to buying Revolution Medicines' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Revolution Medicines are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Revolution Current Options Market Mood
Revolution Medicines' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Revolution Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Revolution Medicines' options investors are not very successful. Revolution Medicines' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Revolution contract
Base on the Rule 16, the options market is currently suggesting that Revolution Medicines will have an average daily up or down price movement of about 0.0356% per day over the life of the 2025-02-21 option contract. With Revolution Medicines trading at USD 40.17, that is roughly USD 0.0143. If you think that the market is fully incorporating Revolution Medicines' daily price movement you should consider buying Revolution Medicines options at the current volatility level of 0.57%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Revolution |
Revolution Medicines Option Chain
When Revolution Medicines' strike price is surpassing the current stock price, the option contract against Revolution Medicines stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Revolution Medicines' option chain is a display of a range of information that helps investors for ways to trade options on Revolution. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Revolution. It also shows strike prices and maturity days for a Revolution Medicines against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | RVMD250221C00035000 | 2 | 35.0 | 5.3 - 6.5 | 10.0 | In |
Call | RVMD250221C00036000 | 4 | 36.0 | 4.2 - 5.4 | 9.68 | In |
Call | RVMD250221C00039000 | 4 | 39.0 | 2.4 - 3.3 | 2.67 | In |
Call | RVMD250221C00040000 | 500 | 40.0 | 1.85 - 2.75 | 2.26 | In |
Call | RVMD250221C00041000 | 1301 | 41.0 | 1.4 - 2.05 | 1.55 | Out |
Call | RVMD250221C00042000 | 622 | 42.0 | 0.75 - 1.85 | 1.15 | Out |
Call | RVMD250221C00043000 | 2 | 43.0 | 0.2 - 1.75 | 1.47 | Out |
Call | RVMD250221C00044000 | 37 | 44.0 | 0.35 - 1.5 | 0.8 | Out |
Call | RVMD250221C00045000 | 3 | 45.0 | 0.35 - 1.2 | 0.75 | Out |
Call | RVMD250221C00046000 | 1297 | 46.0 | 0.25 - 0.85 | 0.5 | Out |
Call | RVMD250221C00047000 | 253 | 47.0 | 0.0 - 0.9 | 1.14 | Out |
Call | RVMD250221C00048000 | 0 | 48.0 | 0.0 - 0.65 | 0.65 | |
Call | RVMD250221C00049000 | 0 | 49.0 | 0.0 - 0.85 | 0.85 | |
Call | RVMD250221C00050000 | 151 | 50.0 | 0.0 - 2.65 | 0.2 | Out |
Call | RVMD250221C00055000 | 1 | 55.0 | 0.0 - 0.7 | 1.06 | Out |
Call | RVMD250221C00060000 | 0 | 60.0 | 0.0 - 4.8 | 4.8 | |
Call | RVMD250221C00065000 | 0 | 65.0 | 0.0 - 1.2 | 1.2 | |
Put | RVMD250221P00038000 | 1 | 38.0 | 0.6 - 1.85 | 0.95 | Out |
Put | RVMD250221P00039000 | 2 | 39.0 | 0.5 - 2.25 | 1.8 | Out |
Put | RVMD250221P00043000 | 8 | 43.0 | 2.65 - 4.7 | 2.8 | In |
Put | RVMD250221P00044000 | 1 | 44.0 | 3.4 - 5.4 | 3.2 | In |
Put | RVMD250221P00045000 | 0 | 45.0 | 4.7 - 5.8 | 4.7 | In |
Put | RVMD250221P00046000 | 0 | 46.0 | 5.7 - 7.1 | 5.7 | In |
Put | RVMD250221P00047000 | 0 | 47.0 | 6.1 - 7.6 | 6.1 | In |
Put | RVMD250221P00048000 | 0 | 48.0 | 6.9 - 10.0 | 6.9 | In |
Put | RVMD250221P00049000 | 0 | 49.0 | 6.9 - 10.8 | 6.9 | In |
Put | RVMD250221P00050000 | 0 | 50.0 | 8.4 - 11.9 | 8.4 | In |
Put | RVMD250221P00055000 | 0 | 55.0 | 12.5 - 17.1 | 12.5 | In |
Put | RVMD250221P00060000 | 0 | 60.0 | 17.7 - 21.8 | 17.7 | In |
Put | RVMD250221P00065000 | 0 | 65.0 | 22.9 - 27.4 | 22.9 | In |
Revolution Medicines Market Cap Over Time
Market Cap |
| Timeline |
Revolution Total Stockholder Equity
Total Stockholder Equity |
|
Revolution Medicines Corporate Management
| David Pompliano | Founding Officer | Profile | |
| Jack Anders | Chief Officer | Profile | |
| Erin Graves | Senior Relations | Profile | |
| Walter Reiher | Chief Officer | Profile | |
| Path FRCP | Pres RD | Profile | |
| Margaret JD | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revolution Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Revolution Stock refer to our How to Trade Revolution Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revolution Medicines. If investors know Revolution will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revolution Medicines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.66) | Revenue Per Share | Quarterly Revenue Growth (0.95) | Return On Assets | Return On Equity |
The market value of Revolution Medicines is measured differently than its book value, which is the value of Revolution that is recorded on the company's balance sheet. Investors also form their own opinion of Revolution Medicines' value that differs from its market value or its book value, called intrinsic value, which is Revolution Medicines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revolution Medicines' market value can be influenced by many factors that don't directly affect Revolution Medicines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revolution Medicines' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revolution Medicines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revolution Medicines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.